{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By STEVEN DAVIDOFF SOLOMON", "person": [{"middlename": "Davidoff", "firstname": "Steven", "lastname": "SOLOMON", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": null, "type_of_material": "News", "word_count": "1468", "lead_paragraph": "Mylan is taking advantage of Dutch takeover defenses to block a hostile bid by Teva Pharmaceuticals, but U.S. market rules may hamper its efforts.", "pub_date": "2015-06-12T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Mylan\u2019s Dutch Takeover Defense Is in Nasdaq\u2019s Hands", "content_kicker": "Deal Professor", "kicker": "Deal Professor"}, "snippet": "Mylan is taking advantage of Dutch takeover defenses to block a hostile bid by Teva Pharmaceuticals, but U.S. market rules may hamper its efforts.", "multimedia": [{"height": 126, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof2-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof2-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 601, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof-drug-articleLarge-v3.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "601", "xlarge": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof-drug-articleLarge-v3.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof3-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof3-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/06/12/business/dealbook/mylans-dutch-takeover-defense-is-in-nasdaqs-hands.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Perrigo Company", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "NASDAQ OMX Group Inc", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Shareholder Rights and Activism", "name": "subject"}], "blog": [], "_id": "5579ea8538f0d82bd01b4ff9", "source": "The New York Times"}